These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3380043)

  • 1. Time to lower cholesterol: the potential effect of cholesterol reduction on the incidence of cardiovascular disease.
    Plant AJ; Pierce JP; Rushworth RL; Goldstein GB
    Med J Aust; 1988 Jun; 148(12):627-9. PubMed ID: 3380043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The awareness of the risk of elevated cholesterol levels and knowledge about cholesterol-lowering action in Australia.
    Rushworth RL; Plant AJ; Pierce JP; Bauman A; Aldrich R; Cripps AL
    Med J Aust; 1990 Jan; 152(2):72-5. PubMed ID: 2296234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry).
    Allen NB; Zhao L; Liu L; Daviglus M; Liu K; Fries J; Shih YT; Garside D; Vu TH; Stamler J; Lloyd-Jones DM
    Circulation; 2017 May; 135(18):1693-1701. PubMed ID: 28461414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.
    Carrington MJ; Retegan C; Johnston CI; Jennings GL; Stewart S
    J Clin Nurs; 2009 Mar; 18(5):678-86. PubMed ID: 19077020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease.
    Hurley SF; Scollo MM; Younie SJ; English DR; Swanson MG
    Med J Aust; 2004 Sep; 181(5):252-5. PubMed ID: 15347272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project.
    Salonen JT; Puska P; Kottke TE; Tuomilehto J
    Am J Epidemiol; 1981 Jul; 114(1):81-94. PubMed ID: 6972694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors in schoolchildren.
    Michel U; Riechers B
    J Am Coll Nutr; 1992 Jun; 11 Suppl():36S-40S. PubMed ID: 1619198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study.
    Simons LA; Simons J; Friedlander Y; McCallum J; Palaniappan L
    Med J Aust; 2003 Feb; 178(3):113-6. PubMed ID: 12558481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest statistics on cardiovascular disease in Australia.
    Waters AM; Trinh L; Chau T; Bourchier M; Moon L
    Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):347-56. PubMed ID: 23517328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interventions to prevent cardiovascular disease in Australia's indigenous population.
    Ong KS; Carter R; Vos T; Kelaher M; Anderson I
    Heart Lung Circ; 2014 May; 23(5):414-21. PubMed ID: 24252448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol and atherosclerosis: a contemporary perspective.
    Kashyap ML
    Ann Acad Med Singap; 1997 Jul; 26(4):517-23. PubMed ID: 9395824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
    Murray CJ; Lauer JA; Hutubessy RC; Niessen L; Tomijima N; Rodgers A; Lawes CM; Evans DB
    Lancet; 2003 Mar; 361(9359):717-25. PubMed ID: 12620735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline implementation in a multicenter study with an estimated 44% relative cardiovascular event risk reduction.
    Onat A; Soydan I; Tokgözoğlu L; Sansoy V; Koylan N; Domaniç N; Ural D;
    Clin Cardiol; 2003 May; 26(5):243-9. PubMed ID: 12769254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pravastatin for cardiovascular event primary prevention in patients with mild-to-moderate hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
    Kushiro T; Mizuno K; Nakaya N; Ohashi Y; Tajima N; Teramoto T; Uchiyama S; Nakamura H;
    Hypertension; 2009 Feb; 53(2):135-41. PubMed ID: 19104004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of smoking in Brazil and potential benefit of increasing taxes on cigarettes for the economy and for reducing morbidity and mortality.
    Pinto M; Bardach A; Palacios A; Biz A; Alcaraz A; Rodriguez B; Augustovski F; Pichon-Riviere A
    Cad Saude Publica; 2019 Aug; 35(8):e00129118. PubMed ID: 31483047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study.
    Schauffler HH; D'Agostino RB; Kannel WB
    Am J Prev Med; 1993; 9(3):146-54. PubMed ID: 8347365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance.
    Venkitachalam L; Wang K; Porath A; Corbalan R; Hirsch AT; Cohen DJ; Smith SC; Ohman EM; Steg PG; Bhatt DL; Magnuson EA;
    Circulation; 2012 Apr; 125(15):1858-69. PubMed ID: 22492667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.